Full metadata record
DC Field | Value | Language |
---|---|---|
dc.creator | Pedro-Botet, J. (Juan) | - |
dc.creator | Ascaso, F.J. (Francisco J.) | - |
dc.creator | Barrios, V. (V.) | - |
dc.creator | Sierra, A. (Alejandro) | - |
dc.creator | Escalada, J. (Javier) | - |
dc.creator | Millán, J. (Jesús) | - |
dc.creator | Mostaza, J.M. (José M.) | - |
dc.creator | Pérez-Martínez, P. (Pablo) | - |
dc.creator | Pinto, X. (Xavier) | - |
dc.creator | Salas-Salvado, J. (Jordi) | - |
dc.creator | Valdivielso, P. (Pedro) | - |
dc.date.accessioned | 2023-03-30T10:31:40Z | - |
dc.date.available | 2023-03-30T10:31:40Z | - |
dc.date.issued | 2018 | - |
dc.identifier.citation | Pedro-Botet, J. (Juan); Ascaso, F.J. (Francisco J.); Barrios, V. (V.); et al. "COSMIC project: consensus on the objectives of the metabolic syndrome in clinic". International journal of literature and arts. 6 (4), 2018, 68 - 76 | es |
dc.identifier.issn | 1178-7007 | - |
dc.identifier.uri | https://hdl.handle.net/10171/65818 | - |
dc.description.abstract | Metabolic syndrome (MetS), a disorder with a high and growing prevalence, is a recognized risk factor for cardiovascular disease (CVD) and type 2 diabetes. It is a constellation of clinical and metabolic risk factors that include abdominal obesity, dyslipidemia, glucose intolerance, and hypertension. Unfortunately, MetS is typically underrecognized, and there is great heterogeneity in its management, which can hamper clinical decision-making and be a barrier to achieving the therapeutic goals of CVD and diabetes prevention. Although no single treatment for MetS as a whole currently exists, management should be targeted at treating the conditions contributing to it and possibly reversing the risk factors. All this justifies the need to develop recommendations that adapt existing knowledge to clinical practice in our healthcare system. In this regard, professionals from different scientific societies who are involved in the management of the different MetS components reviewed the available scientific evidence focused basically on therapeutic aspects of MetS and developed a consensus document to establish recommendations on therapeutic goals that facilitate their homogenization in clinical decision-making. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Taylor and Francis Group | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.subject | Cardiovascular prevention | es_ES |
dc.subject | Diabetes prevention | es_ES |
dc.subject | Insulin resistance | es_ES |
dc.subject | Hypertension | es_ES |
dc.subject | Dyslipidemia | es_ES |
dc.subject | Obesity | es_ES |
dc.title | COSMIC project: consensus on the objectives of the metabolic syndrome in clinic | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.description.note | This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms. php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). | es_ES |
dc.identifier.doi | 10.11648/j.ijla.20180604.12 | - |
dadun.citation.endingPage | 76 | es_ES |
dadun.citation.number | 4 | es_ES |
dadun.citation.publicationName | International journal of literature and arts | es_ES |
dadun.citation.startingPage | 68 | es_ES |
dadun.citation.volume | 6 | es_ES |
Files in This Item:
Statistics and impact
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.